From Scientist to Analyst to Strategist: Aharon (Ronny) Gal Talks with Ken Herrmann and Johannes Czernin About Leadership in Multinational Pharma

By sjmartinez • January 18, 2025

Gal AR, Herrmann K, Czernin J. From Scientist to Analyst to Strategist: Aharon (Ronny) Gal Talks with Ken Herrmann and Johannes Czernin About Leadership in Multinational Pharma. J Nucl Med. 2025 Jan 16:jnumed.124.269177. doi: 10.2967/jnumed.124.269177. Epub ahead of print. PMID: 39819691.

Tags: Cardiology/Epi, Publications

Trends in Cardiovascular Mortality in Patients With Chronic Kidney Disease From 1999 to 2020: A Retrospective Study in the United States

Ahmad E, Ahmad S, Naeem A, Ahmed S, Shehzad M, Akram U, Ashraf H, Rehman OU, Ullah I, Ahmed R, Alraies C, Fonarow GC. Trends[...]

Right Coronary Artery Occlusion due to Adventitial Hematoma During Cavotricuspid Isthmus Ablation

Asada H, Takami M, Mori S, Izawa Y, Kawamori H, Fukuzawa K. Right Coronary Artery Occlusion due to Adventitial Hematoma During Cavotricuspid Isthmus Ablation. JACC[...]

Diabetes and longitudinal changes in deep learning-derived measures of vertebral bone mineral density using conventional CT: the Multi-Ethnic Study of Atherosclerosis

Ghotbi E, Hadidchi R, Hathaway QA, Bancks MP, Bluemke DA, Barr RG, Smith BM, Post WS, Budoff M, Lima JAC, Demehri S. Diabetes and longitudinal[...]